The federal government recently announced the creation of the $25 million BioCanRx, one of five national research networks designed to tackle some of the world's major health and life science issues. Economics Department Adjunct Professor Christopher McCabe was included in the network for his expertise in developing the evidence base to determine whether a medical innovation has economic viability and effectiveness. This information is needed to decide which candidate technologies should be advanced to trials and how those trials should be designed. McCabe says his inclusion in the network indicates the importance of the evidence requirement in designing clinical translation programs for innovative technologies.
For more information, see the U of A story